Icon Contactez-nous

Publications

HEVA > Publications > A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions

A multi-center evaluation of clinical pathways cost and time using real-life data in patients treated for their breast cancer by Trastuzumab intravenous and subcutaneous in day sessions

PMSI oncologie article
Auteurs: Cécile Blein, Chantal Bernard-Marty, Véronique Priou, Marie-Claude Borg, Marie-Ange Mouret-Reynier, Gaelle Lebozec, Jean-François Tournamille, Anne Jaffré, Nathalie Perez-staub, Raphael Alfonsi, Nadia Bahmad, Hanane Attar-Rabia
Date de publication: 1 janvier 2018
Document Document
Accéder à la publication